KURA

Kura Oncology Inc (KURA)

US
$ 17.68-0.51%

Price Chart

Key Statistics

Market Cap
$ 540.23M
P/E Ratio
0.00
Revenue (TTM)
$ 67.99M
Volume
687.01K
52W High
$ 23.48
52W Low
$ 5.41
Dividend Yield
0.00%
Beta
0.50

Technicals

50-Day MA
6.4849
200-Day MA
12.1442
52 Week High
23.48
52 Week Low
5.41

About KURA

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Employees
192
Headquarters
San Diego, CA
CEO
Dr. Troy Edward Wilson J.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg